Home Gilead Has Bottomed - The Question Is How Much Upside Ahead?
 

Keywords :   


Gilead Has Bottomed - The Question Is How Much Upside Ahead?

2016-02-16 05:34:09| Biotech - Topix.net

It has been a frightful six months for biotech investors as the main biotech indices have plunged some 40% from their peaks in July. However, it does appear the some of the big biotech names are in a bottoming phase which is needed before the sector can rally.

Tags: much question ahead upside

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »